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Abstract
Introduction. Corynebacterium ulcerans can produce diphtheria toxin and although still rare, is now the predominant cause of 
toxigenic diphtheria infection in the UK, making this organism of great clinical and public health importance. Here we describe 
a cutaneous case, likely secondary to domestic animal contact.
Case presentation. A 60-year-old female presented with a slow-healing finger-burn wound. A skin swab cultured Corynebac-
terium ulcerans, which was confirmed to be toxin producing. She resided with her partner and two dogs, one of which had a 
chronic skin lesion. Her most recent diphtheria vaccine was in 2009. Four close contacts were identified, two of whom were 
healthcare professionals, and nose and throat swabs were obtained. The patient was treated with clarithromycin (14 day 
course), diphtheria vaccine and excluded from work until completion of antibiotics and negative clearance swabs. Contacts 
were given erythromycin (7 day course), vaccinated and healthcare worker contacts excluded from work until swab negative. A 
veterinary practitioner swabbed the throats and a skin lesion of their dogs. One contact (partner of patient) and all dog swabs 
were positive. Partial allelic profiles from MLST supported an epidemiological link. The dogs were treated with antibiotics and 
antimicrobial skin wash. Repeat swabs for the index case, contact and both dogs were negative following treatment.
Conclusion. This was a rare case of cutaneous diphtheria secondary to Corynebacterium ulcerans with domestic animals the 
most likely source, although human-to-human contact could not be excluded, with important human and animal public health 
implications.
InTROduCTIOn
Corynebacterium ulcerans is an aerobic Gram-positive 
bacillus, which is capable of producing diphtheria exotoxin 
making identification of this organism of great clinical and 
public health importance. It is a zoonotic infection, histori-
cally associated with cattle, and other domestic animals 
including cats and dogs [1, 2]. Corynebacterium ulcerans has 
also been recovered from wild animals, including otters in 
Scotland and England [3]. Infection with C. ulcerans can cause 
the clinical syndromes of respiratory or cutaneous diphtheria. 
Cases of diphtheria may present with skin lesions that are 
indicative of cutaneous diphtheria, or respiratory symptoms 
associated with pseudo-membranes covering the trachea or 
bronchi [4, 5].
Human infection with C. ulcerans can be fatal and four 
deaths have occurred in the UK between 1986 and 2014 [6]. 
Although extremely rare, with 11 cases of diphtheria caused 
by C. ulcerans occurring in Europe in 2012 [7], the frequency 
and severity of infections associated with C. ulcerans appears 
to be increasing [2]. In addition, C. ulcerans has been the 
predominant cause of toxigenic infection in the UK since 
the 1990s, when C. diphtheriae was more common [8]. The 
reasons for this change in epidemiology is not clear, but may 
be related to pet ownership, as it is estimated that half of all UK 
households own a pet [9]. The majority of cases of C. ulcerans 
associated with zoonotic infection occurred in adults who had 
been partially or fully vaccinated with diphtheria toxoid [10]. 
It usually occurs in humans with a history of close animal 
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contact, although previously it was thought that C. ulcerans 
was acquired from contact with cattle or consumption of raw 
dairy products, in more recent years, cases are increasingly 
associated with companion animals [4, 5, 11, 12]. A number 
of other species have been identified as carriers, including 
domestic pets and the pathogen has been identified in healthy 
dogs in urban areas of a number of countries [10, 13]. In the UK, 
there have been few cases of documented cutaneous toxigenic 
C. ulcerans infection associated with domestic animals 
[14] and [15]. Human–human transmission of toxigenic 
C. ulcerans is rare with only one report of a respiratory 
case documented [16]. Between 1986 and 2008 in the UK, 
C. ulcerans was identified in asymptomatic carriers of two 
separate cases of respiratory diphtheria [17]. There have been 
no documented cases of human–human transmission of 
C. ulcerans with a cutaneous presentation. Here we present 
a case of C. ulcerans skin infection due to domestic animal 
contact.
CASE REPORT
In 2017, a 60-year-old female presented to her General Prac-
titioner (GP) in Scotland with a slow-healing 1 cm wound 
on her right finger. She had sustained a minor burn to the 
finger 9 days prior to her attendance. A swab was taken by the 
attending clinician. This swab subsequently grew toxigenic 
C. ulcerans. This result was telephoned to the out-of-hours 
local health protection team, 8 days after the case presented 
to her GP.
The case lived with her partner and owned two German 
Shepherd dogs. One dog had a history of a long-standing 
skin complaint, which had been documented as quiescent. 
The case worked in retail and had no recent travel history. 
She had not eaten unpasteurized dairy food nor visited any 
farms within the last 2 weeks. Her most recent diphtheria 
vaccination was in 2009.
A nose and throat swab were collected from the patient and 
she was treated with diphtheria vaccine and a 2 week course of 
clarithromycin. She was excluded from work under the Public 
Health Act Scotland (2009) until completion of antibiotics 
and clearance swabs, one from each site (nose, throat and 
wound) were negative. Four close contacts were identified 
who required nose and throat swabs to assess for carriage 
of C. ulcerans, of whom two were healthcare professionals 
who had dressed the wound. Contacts were all given diph-
theria vaccine and a 1 week course of erythromycin. The two 
healthcare workers were excluded from work until nose and 
throat swabs were culture negative. One contact (husband) 
was identified as carrying C. ulcerans in his nose and required 
a repeat swab following completion of antibiotics to check for 
clearance. His repeat swab was culture negative. Initial swabs 
for the fourth contact (a close friend) were negative.
A local veterinary practitioner examined the dogs, which 
revealed one had an infected skin lesion, which was swabbed. 
Throat swabs were also collected from both dogs. Toxigenic 
C. ulcerans was recovered in culture from the skin lesion 
and throat swabs of both dogs. They were commenced on 
antibiotic therapy and antimicrobial skin wash. Repeat swabs 
for the dogs were negative following completion of treatment. 
The dogs were identified as the most likely source of infection, 
however, it is possible human–human transmission may have 
occurred.
Microbiology investigations
Wound swab was submitted for routine culture and was 
inoculated on Columbia blood agar (Thermo-Fisher, Perth, 
UK). Large numbers of C. ulcerans were cultured and 
identified using MALDI-TOF (MALDI Biotyper, Bruker, 
Massachusetts, USA). MALDI-TOF generates unique mass 
spectrometry profiles, which are compared to a known data-
base of micro-organism profiles, identifying the organism to 
genus and species levels [18]. The MALDI-TOF score was 
>2.0, which is an acceptable score for species identification. 
Susceptibility testing was performed by E-test (bioMérieux) 
using European Society of Clinical Microbiology and Infec-
tious Disease (EUCAST) interpretative criteria. The isolate 
was sent to the Diphtheria National Reference Laboratory, 
Public Health England (PHE), Colindale, London, where 
the isolates were characterized by genotypic and phenotypic 
methods. In April 2014, a real-time PCR (qPCR) assay was 
formally introduced as the front-line test for putative toxi-
genic corynebacteria to inform public health action [19]. 
This assay provides confirmation of both identification of 
C. diphtheriae and C. ulcerans/C. pseudotuberculosis and detec-
tion of the diphtheria toxin gene. Phenotypic characterization 
was perfomed by culture on Columbia horse blood, Hoyle’s 
tellurite and Tinsdale agar plates (PHE Media Services, Colin-
dale); API Coryne (bioMerieux) and additional differential 
biochemical tests (e.g. nitrate reduction, glycogen hydrolysis 
as required [20]. The modified Elek immunodiffusion test 
[21] was used to confirm toxin expression. Further genotypic 
characterization of isolates was performed by MLST as previ-
ously described [22, 23]. The clinical isolate from the index 
case was identified as C. ulcerans/C.diphtheriae, diphtheria 
toxin gene positive by qPCR. The species was confirmed as 
C. ulcerans phenotypically and toxin expression was 
confirmed by the Elek test. Antimicrobial susceptibility testing 
results were also confirmed at the reference laboratory and it 
showed resistance to penicillin and clindamycin but sensi-
tivity to vancomycin, erythromycin, linezolid, ciprofloxacin, 
doxycycline and rifampicin. S. aureus was isolated along with 
C. ulcerans. S. aureus could be colonizing the skin but was 
also likely contributing to any skin and soft tissue infection.
C. ulcerans was also isolated from a nose swab from the close 
contact of the index case and this was confirmed as toxigenic 
C. ulcerans as above. Throat swabs from the two dogs and the 
skin lesion were collected by their veterinary practitioner and 
submitted to SAC Consulting Veterinary Services laboratory 
in Inverness where they were cultured on Columbia sheep 
blood agar and Hoyles tellurite medium (Thermo-Fisher, 
Perth, UK). C. ulcerans was obtained in moderate growth 
from the throat swabs collected from each dog and in heavy 
growth from the wound. The wound also contained a heavy 
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growth of Staphylococcus schleiferi subsp. coagulans, and an 
unidentified Gram-positive coccus. Suspect C. ulcerans were 
identified with the API Coryne system. Follow-up samples 
were collected from the throats of both dogs after treatment 
was completed and C. ulcerans was not detected. Further-
more, the skin lesion had resolved and neither C. ulcerans, 
S. schleiferi subsp. coagulans nor the unidentified Gram-
positive coccus were detected. The three canine isolates from 
the two dogs were also confirmed as toxigenic C. ulcerans.
The six isolates (three human, three canine) were subjected 
to MLST analysis. Full profiles were not obtained, most 
likely due to variation in primer binding sites. However, of 
the partial alleleic profiles obtained (range 2 to 5 out of 7 
alleles); all alleles occurring in >1 isolate matched and there 
were no mismatches, supporting an epidemiological link. All 
partial allelic profiles obtained (0, 41, 79, 49, 0, 45, 39) were 
consistent with sequence type 349 (42, 41, 79, 49, 49, 45, 39), 
which is present in the MLST database (https:// pubmlst. org/ 
cdiphtheriae/) [24], from C. ulcerans isolated from a cuta-
neous clinical case in 2005, from Toulouse, France.
dISCuSSIOn
Due to the rarity of this case, a literature review was carried 
out to identify relevant evidence of C. ulcerans and domestic 
animals. MEDLINE was searched for combinations of the 
terms ‘Corynebacterium ulcerans’, ‘diphtheria’, ‘zoonoses’ and 
‘human’, limited to English only, from 1966 to date. Eight 
individual case reports were identified. The study charac-
teristics are summarized in Table 1. Three of the eight cases 
involved dogs, and of these, one had cutaneous presentation. 
Our case was distinct from any of those identified in the 
literature for several reasons. Within the household, the case 
presented with cutaneous diphtheria and an asymptomatic 
carrier was also identified. This may represent the first case 
of human–human transmission of C. ulcerans in a cutaneous 
case. However, we acknowledge that both human infections 
may have been acquired from the dogs. In addition, our case 
was normally healthy with a history of minor trauma causing 
a wound. In other reported cases, the patients had a history of 
chronic illness that may have made them more susceptible to 
infection. The apparent increasing incidence of C. ulcerans, 
and the potential of the microbe to cause infection beyond 
the opportunistic spectrum suggests that this potentially 
deadly infection requires increased vigilance from public 
health.
Implications for public health
The number of cases of diphtheria caused by toxigenic 
C. ulcerans with an epidemiological link to domestic animals 
is small, but rising [8]. Several deaths have been associated 
with C. ulcerans, both within the UK, and outside [7]. This case 
highlighted some of the challenges of managing diphtheria 
that could have significant impact on future management if 
cases continue to rise. Due to the rarity of this condition and 
the widespread diphtheria vaccination programme, recogni-
tion and diagnosis of cutaneous diphtheria may be delayed. 
This can lead to delay in treatment of the case, but also contact 
tracing and identification of a potential source.
The evidence base for the risk factors for acquisition 
of C. ulcerans is limited. The association with domestic 
companion animals who carry the organism is becoming 
increasingly apparent. However, although cases of 
C. ulcerans may have a history of contact with domestic 
pets, microbiological evidence of a link is often unavailable 
as the animals have only been investigated in more recent 
years [17]. Our case highlights the importance of identifying 
the source through epidemiological and microbiological 
investigation. Currently, national guidance for the manage-
ment of diphtheria is available in the UK, provided by Public 
Health England [8]. However, this guidance does not include 
management of animal contacts. C. ulcerans is not a notifiable 
organism if detected in animals, including those implicated in 
human infection and guidance relating to the management of 
animals in a case such as this is not readily available. This is 
a potential area for development as the evidence base for this 
infection continues to expand.
Table 1. Summary of clinical features and transmission data of C. ulcerans infections from case reports from 1966–present (English language only)
Reference Transmission Clinical presentation Other features
[25] Dog–human Severe dyspnoea Case was immunosuppressed
[26] Dog–human Sore throat Case died
[27] Cat–human Sore throat Case had rheumatoid arthritis
[28] Cat–human Skin Case previously well
[29] Cat–human Skin Case died
[30] Cat–human Skin Case was immunosuppressed
[16] Human–human Sore throat Domestic cat in household
[31] Dog – human Skin Case had history of chronic venous insufficiency
[14] Cats, dogs, fox–human Skin Case previously well
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Due to the multiagency management required in this case, 
we recommend that both human and animal public health 
is considered in the investigation and management of cases 
of C. ulcerans in the future. This is consistent with the One 
Health approach [32]. The complexities of case management 
that need to be addressed, include the following: assessing 
the risk in the individual, the public and the animal popula-
tion; management of exclusion of cases, contacts and pets; 
and clinical and financial responsibilities of agencies in the 
assessment, investigation and treatment of cases, contacts 
and domestic companions. Through a co-ordinated approach, 
further research should be conducted into the prevention and 
management of this increasingly prevalent and potentially 
deadly infection, acknowledging the threat to animals and 
humans.
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